PHARMACIA NICOTINE NASAL SPRAY DISTRIBUTION RECORDS
This article was originally published in The Tan Sheet
Executive Summary
PHARMACIA NICOTINE NASAL SPRAY DISTRIBUTION RECORDS should be required to help prevent abuse of the smoking cessation product if it is approved for marketing, FDA's Drag Abuse Advisory Committee recommended Aug. 1. The committee also recommended that a limit be imposed on the number of refill prescriptions patients could obtain without reassessment by the prescriber. The panel recommended against requiting triplicate prescriptions or secured storage areas for the product. Pharmacia's NDA for the nicotine nasal spray as a prescription aid to smoking cessation was filed in July 1993.